Sign in
8-K

Current Report

Cadrenal Therapeutics, Inc. Filed Acc 0001013762-24-003209

Executive or director change · Shareholder vote results

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea0210326-8k_cadrenal.htm…